Filed: 2/13/2025ACC: 0000908834-25-000074
📋 What this filing means
ESSEX WOODLANDS MANAGEMENT, INC. filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $433.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$433.22M
Total AUM (reported)
49.15M
Total Shares
Allocation by class
COM$285.46M65.9%
COM CL A$136.72M31.6%
COM NEW$11.04M2.5%
Portfolio Concentration
Top 3$420.38M97.0%
4–10$12.84M3.0%
Top 3 weight
97.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 49.15M
Sole
Full voting authority
49.15M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:
MIMEDX GROUP, INC.
SOLEShares28.20M
TypeSH
Market value$271.24M
62.61%
Sole
28.20M
Shared
0.00
None
0.00
BIOVENTUS
SOLEShares13.02M
TypeSH
Market value$136.72M
31.56%
Sole
13.02M
Shared
0.00
None
0.00
TELA BIO, INC.
SOLEShares4.11M
TypeSH
Market value$12.41M
2.87%
Sole
4.11M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.17M
TypeSH
Market value$8.72M
2.01%
Sole
1.17M
Shared
0.00
None
0.00
MEDICINOVA INC
SOLEShares1.11M
TypeSH
Market value$2.32M
0.54%
Sole
1.11M
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares457.08K
TypeSH
Market value$1.39M
0.32%
Sole
457.08K
Shared
0.00
None
0.00
VENUS CONCEPT, INC.
SOLEShares1.09M
TypeSH
Market value$413.9K
0.10%
Sole
1.09M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MIMEDX GROUP, INC.SOLE | COM | 28.20M | SH | $271.24M 62.61% | 28.20M | 0.00 | 0.00 |
BIOVENTUSSOLE | COM CL A | 13.02M | SH | $136.72M 31.56% | 13.02M | 0.00 | 0.00 |
TELA BIO, INC.SOLE | COM | 4.11M | SH | $12.41M 2.87% | 4.11M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.17M | SH | $8.72M 2.01% | 1.17M | 0.00 | 0.00 |
MEDICINOVA INCSOLE | COM NEW | 1.11M | SH | $2.32M 0.54% | 1.11M | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 457.08K | SH | $1.39M 0.32% | 457.08K | 0.00 | 0.00 |
VENUS CONCEPT, INC.SOLE | COM | 1.09M | SH | $413.9K 0.10% | 1.09M | 0.00 | 0.00 |